INVEX Controladora. de Inkomsten in het verleden
Verleden criteriumcontroles 5/6
INVEX Controladora. de has been growing earnings at an average annual rate of 15.5%, while the Diversified Financial industry saw earnings growing at 18.1% annually. Revenues have been growing at an average rate of 18.2% per year. INVEX Controladora. de's return on equity is 9.5%, and it has net margins of 17.2%.
Belangrijke informatie
15.5%
Groei van de winst
15.5%
Groei van de winst per aandeel
| Diversified Financial Groei van de industrie | 14.6% |
| Inkomstengroei | 18.2% |
| Rendement op eigen vermogen | 9.5% |
| Nettomarge | 17.2% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe INVEX Controladora. de geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 8,613 | 1,483 | 0 | 0 |
| 30 Jun 24 | 8,299 | 1,458 | 0 | 0 |
| 31 Mar 24 | 5,249 | 1,292 | 0 | 0 |
| 31 Dec 23 | 7,095 | 1,044 | 0 | 0 |
| 30 Sep 23 | 6,701 | 1,148 | 0 | 0 |
| 30 Jun 23 | 6,225 | 1,022 | 0 | 0 |
| 31 Mar 23 | 6,079 | 1,168 | 0 | 0 |
| 31 Dec 22 | 5,791 | 1,360 | 0 | 0 |
| 30 Sep 22 | 4,685 | 1,296 | 0 | 0 |
| 30 Jun 22 | 4,702 | 1,362 | 0 | 0 |
| 31 Mar 22 | 4,436 | 1,262 | 0 | 0 |
| 31 Dec 21 | 4,431 | 1,218 | 0 | 0 |
| 30 Sep 21 | 4,259 | 1,058 | 0 | 0 |
| 30 Jun 21 | 3,021 | 919 | 0 | 0 |
| 31 Mar 21 | 3,603 | 843 | 0 | 0 |
| 31 Dec 20 | 3,803 | 564 | 0 | 0 |
| 30 Sep 20 | 3,417 | 660 | 0 | 0 |
| 30 Jun 20 | 4,409 | 583 | 0 | 0 |
| 31 Mar 20 | 4,016 | 605 | 0 | 0 |
| 31 Dec 19 | 3,698 | 804 | 0 | 0 |
| 30 Sep 19 | 3,142 | 694 | 0 | 0 |
| 30 Jun 19 | 6,275 | 668 | 0 | 0 |
| 31 Mar 19 | 3,191 | 696 | 0 | 0 |
| 31 Dec 18 | 3,045 | 604 | 0 | 0 |
| 30 Sep 18 | 2,774 | 577 | 0 | 0 |
| 30 Jun 18 | -375 | 570 | 0 | 0 |
| 31 Mar 18 | 2,790 | 488 | 0 | 0 |
| 31 Dec 17 | 3,384 | 793 | 0 | 0 |
| 30 Sep 17 | 3,247 | 748 | 0 | 0 |
| 30 Jun 17 | 3,240 | 796 | 0 | 0 |
| 31 Mar 17 | 3,099 | 816 | 0 | 0 |
| 31 Dec 16 | 2,575 | 541 | 0 | 0 |
| 30 Sep 16 | 2,443 | 563 | 0 | 0 |
| 30 Jun 16 | 2,140 | 442 | 0 | 0 |
| 31 Mar 16 | 2,020 | 415 | 0 | 0 |
| 31 Dec 15 | 1,875 | 361 | 0 | 0 |
| 30 Sep 15 | 1,669 | 294 | 0 | 0 |
| 30 Jun 15 | 1,755 | 375 | 0 | 0 |
| 31 Mar 15 | 1,676 | 351 | 0 | 0 |
| 31 Dec 14 | 1,667 | 375 | 0 | 0 |
| 30 Sep 14 | 1,833 | 417 | 0 | 0 |
| 30 Jun 14 | 1,906 | 439 | 0 | 0 |
| 31 Mar 14 | 1,716 | 359 | 0 | 0 |
| 31 Dec 13 | 1,762 | 401 | 0 | 0 |
Kwaliteitswinsten: INVEX A has high quality earnings.
Groeiende winstmarge: INVEX A's current net profit margins (17.2%) are higher than last year (17.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: INVEX A's earnings have grown by 15.5% per year over the past 5 years.
Versnelling van de groei: INVEX A's earnings growth over the past year (29.1%) exceeds its 5-year average (15.5% per year).
Winst versus industrie: INVEX A earnings growth over the past year (29.1%) exceeded the Diversified Financial industry 9.5%.
Rendement op eigen vermogen
Hoge ROE: INVEX A's Return on Equity (9.5%) is considered low.